At the end of Q2 2026, 20 institutions reported holding Proshares Ultra Nasd Biotech (BIB) in their 13F filings, down 3 from Q1 2026. 4 opened new positions and 7 sold out. The largest holders were Susquehanna International Group, LLP ($786K), Capital Investment Advisors, LLC ($599K) and Kaizen Financial Strategies ($536K).
Company
Proshares Ultra Nasd Biotech
CUSIP
74347R214
Latest filing quarter
Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
Institutions
Total Value
New Positions
4
$498K
Exits
7
$981K
All 13F filers, Q1 2026 → Q2 2026: 4,981 shares bought and 17,794 shares sold, net −12,813 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.